Showing results (61-70 of 70) with videos related to
Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Therapeutic Advances in Medical Oncology|March 15, 2021
A phase II study of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small-cell lung cancer in Japan (SAMURAI study)Shigeru Tanzawa, Sunao Ushijima, Kazuhiko Shibata, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|June 23, 2020
Nationwide surveillance of bacterial respiratory pathogens conducted by the surveillance committee of japanese society of chemotherapy, the japanese association for infectious diseases, and the japanese society for clinical microbiology in 2016: General view of the pathogens' antibacterial susceptibilityKatsunori Yanagihara, Tetsuya Matsumoto, Issei Tokimatsu, et al.Open Forum Infectious Diseases|July 13, 2023
Propensity-Score Matched Analysis of the Effectiveness of Baricitinib in Patients With Coronavirus Disease 2019 (COVID-19) Using Nationwide Real-World Data: An Observational Matched Cohort Study From the Japan COVID-19 Task ForceHiromu Tanaka, Shotaro Chubachi, Ho Namkoong, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|June 15, 2019
Nationwide surveillance of bacterial respiratory pathogens conducted by the surveillance committee of Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for clinical microbiology in 2014: General view of the pathogens' antibacterial susceptibilityKatsunori Yanagihara, Tetsuya Matsumoto, Nobuki Aoki, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|July 7, 2012
Nationwide surveillance of bacterial respiratory pathogens conducted by the Surveillance Committee of Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Clinical Microbiology in 2009: general view of the pathogens' antibacterial susceptibilityAkira Watanabe, Katsunori Yanagihara, Tetsuya Matsumoto, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|March 31, 2015
Nationwide surveillance of bacterial respiratory pathogens conducted by the surveillance committee of Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for Clinical Microbiology in 2010: General view of the pathogens' antibacterial susceptibilityKatsunori Yanagihara, Junichi Kadota, Nobuki Aoki, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|January 22, 2023
Diagnostic significance of secondary bacteremia in patients with COVID-19Kensuke Nakagawara, Hirofumi Kamata, Shotaro Chubachi, et al.BMC Pulmonary Medicine|April 26, 2023
Impact of respiratory bacterial infections on mortality in Japanese patients with COVID-19: a retrospective cohort studyKensuke Nakagawara, Hirofumi Kamata, Shotaro Chubachi, et al.Nature Communications|August 22, 2022
The whole blood transcriptional regulation landscape in 465 COVID-19 infected samples from Japan COVID-19 Task ForceQingbo S Wang, Ryuya Edahiro, Ho Namkoong, et al.Nature|August 8, 2022
DOCK2 is involved in the host genetics and biology of severe COVID-19Ho Namkoong, Ryuya Edahiro, Tomomi Takano, et al.Pageof 7